Page last updated: 2024-09-20

2,4-dichlorophenoxyacetic acid methyl ester

Cross-References

ID SourceID
PubMed CID1488
CHEMBL ID1327631
SCHEMBL ID5004223
MeSH IDM0190715

Synonyms (82)

Synonym
KBIO1_001512
DIVK1C_006568
ai3-14625
2,4-dichlorophenoxyacetic acid, methyl ester
epa pesticide chemical code 030067
2,4-d-methyl [iso]
brn 2053392
einecs 217-670-7
caswell no. 315aw
ccris 1458
2,4-d-methyl
methyl 2,4-dichlorophenoxyacetate
nsc 9399
SPECTRUM_001861
acetic acid,4-dichlorophenoxy)-, methyl ester
2,4-d methyl ester
methyl (2,4-dichlorophenoxy)acetate
1928-38-7
nsc9399
methyl 2,4-d ester
nsc-9399
(2, methyl ester
2,4-dichlorophenoxyacetic acid methyl ester
acetic acid, (2,4-dichlorophenoxy)-, methyl ester
SPECTRUM5_001986
BSPBIO_002391
2,4-d methyl ester, analytical standard
NCGC00094534-02
NCGC00094534-01
KBIOGR_001111
KBIOSS_002378
KBIO2_007510
KBIO2_004942
KBIO2_002374
KBIO3_001891
SPECTRUM3_000836
SPBIO_001662
SPECTRUM2_001851
SPECPLUS_000472
SPECTRUM4_000676
SPECTRUM330044
NCGC00094534-03
AKOS001581160
methyl 2-(2,4-dichlorophenoxy)acetate
sg8721q1o5 ,
unii-sg8721q1o5
cas-1928-38-7
tox21_301422
NCGC00255411-01
dtxsid6041349 ,
dtxcid4021349
CCG-39389
FT-0633918
CHEMBL1327631
(2,4-dichlorophenoxy)acetic acid methyl ester
acetic acid, 2-(2,4-dichlorophenoxy)-, methyl ester
2,4-d, methyl ester
SCHEMBL5004223
2,4-d-methyl ester
STL426119
BBL034670
(2,4-dichlorophenoxy)acetic acid, methyl ester
methyl ester of 2,4-dichlorophenoxyacetic acid
(2,4-dichlorophenoxy) acetic acid, methyl ester
HWIGZMADSFQMOI-UHFFFAOYSA-N
J-521802
methyl 2-(2,4-dichlorophenoxy)-acetate
F0850-6568
sr-01000596974
SR-01000596974-1
mfcd00018356
2,4-d methyl ester, pestanal(r), analytical standard
J-012479
2,4-d-methylester
VS-12633
methyl 2,4-dichloro phenoxyethanoate
Q22329230
methyl2-(2,4-dichlorophenoxy)acetate
CS-0086889
F87217
2,4-dichlorophenoxy acetic acid-methyl ester
EN300-1266013

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency50.11875.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency44.78530.007215.758889.3584AID1224835
SMAD family member 2Homo sapiens (human)Potency30.89560.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency30.89560.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency10.87070.000714.592883.7951AID1259369
thyroid stimulating hormone receptorHomo sapiens (human)Potency34.37620.001628.015177.1139AID1224843
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]